Application for research fellowships by May 25,2017

The Foundation offers annual research fellowships that will lead to a treatment for ARSACS.  A $100,000 grant could be awarded for a period of one year with possibility for renewal for a second year. Researchers interested should apply at the latest  by May 25,...

Save the date

Thursday October 26, 2017. Save the date so you will not miss the annual “Dîner des Producteurs”  

Drug screening molecules- Analysis of first results

ARSACS researchers will be at the  Institute for Research in Immunology and Cancer at the University of Montreal (IRIC) on December 13, 2016 to analyze in greater details the first results of the drug screening therapeutic molecules carried out over the last months ....

4th International Symposium on ARSACS

Several researchers from different countries participated in the 4th Symposium on ARSACS held on November 10 & 11, 2016  at the Neuro in Montreal. This conference provided an opportunity for researchers to share their knowledge and to discuss...

Collaboration with the University of Saskatchewan

   The Foundation is pleased to announce  a co-funding collaboration with the University of Saskatchewan, recognizing the strong support from the Richardson Family Fund, to advance medical research on ataxia of Charlevoix-Saguenay. Press Release...

Success! Growth of cells from ARSACS patient skin

Dr. Paul Chapple’s lab has successfully grown cells from a small biopsy of ARSACS patient skin and has reprogrammed them to become stem cells which can turn into other cell types. The following step was to grow ARSACS neurons from such stem cells. This resulted...

Alliance between ARSACS Foundation and Ataxia UK

The Ataxia of Charlevoix-Saguenay Foundation and Ataxia UK are pleased to announce a co-funding alliance to support and to advance medical research in the UK on ataxia of Charlevoix-Saguenay. This alliance is clear evidence of openness and commitment towards...

Care4Rare Year 3 – progress report

Care4Rare is a research project to identify therapeutic leads for rare diseases such as ARSACS. The Foundation is financing the ARSACS portion under the leadership of Dr. Kym Boycott and Dr. Alex MacKenzie from the Children Hospital of Eastern Ontario.  Year 3...

ARSACS case reported from South India

A group of researchers in South India under the leadership of Dr. M Suraj Menon Department of Neurology, Government TD Medical College, Alappuzha India have reported an ARSACS case from South India. See article.    

Publication by Dr. Erceg on hiPSC

Dr. Salven Erceg  from Spain has published an article  in the Neuroscientist on the human induced pluripotent stem cells (hiPSC). This  article  is an outcome of the research  financed by the ARSACS Foundation.     Read more

“Caractérisation des déficiences, limitations d’activités et restrictions de participation ainsi que de leurs interrelations chez les personnes atteintes d’ataxie Charlevoix-Saguenay (ARSACS)”- Dr Luc Hébert

Description à venir   Durée: un an Bourse : $98,000 Contact: Dr.Luc Hébert , Chercheur, CIRRIS, Bureau H-1702 . IRDPQ, 525 boulevard Hamel, Québec QC  G1M 2S8 Téléphone: 418-529-9141 poste 6579  Courriel :  lucj.hebert@fmed.ulaval.ca;...